NORTHERN TRUST CORP - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 17 filers reported holding VIRPAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,175
-25.9%
15,2210.0%0.00%
Q2 2023$16,439
+37.6%
15,2210.0%0.00%
Q1 2023$11,948
+26.1%
15,2210.0%0.00%
Q4 2022$9,472
-47.4%
15,2210.0%0.00%
Q3 2022$18,000
-30.8%
15,2210.0%0.00%
Q2 2022$26,000
-23.5%
15,2210.0%0.00%
Q1 2022$34,000
-34.6%
15,2210.0%0.00%
Q4 2021$52,00015,2210.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 701,455$550,6420.48%
Quantum Private Wealth, LLC 10,000$7,8500.00%
Warberg Asset Management LLC 17,012$13,3540.00%
Belpointe Asset Management LLC 19,045$14,9500.00%
OSAIC HOLDINGS, INC. 600$4710.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$79,1870.00%
WELLS FARGO & COMPANY/MN 60$470.00%
NORTHERN TRUST CORP 15,221$11,9480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$51,6080.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders